| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 13 | 2023 | 259 | 3.280 |
Why?
|
| Chronic Disease | 16 | 2021 | 962 | 3.170 |
Why?
|
| Child Health Services | 13 | 2021 | 47 | 3.120 |
Why?
|
| Radiography, Thoracic | 4 | 2025 | 327 | 1.660 |
Why?
|
| Health Services Needs and Demand | 8 | 2023 | 110 | 1.590 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2025 | 2592 | 1.550 |
Why?
|
| Home Care Services | 8 | 2022 | 77 | 1.500 |
Why?
|
| Child | 47 | 2024 | 7359 | 1.490 |
Why?
|
| Fee-for-Service Plans | 3 | 2024 | 30 | 1.420 |
Why?
|
| Insurance, Health | 5 | 2021 | 180 | 1.250 |
Why?
|
| Health Care Reform | 4 | 2018 | 83 | 1.250 |
Why?
|
| Lung Neoplasms | 8 | 2025 | 2368 | 1.120 |
Why?
|
| Delivery of Health Care | 3 | 2024 | 453 | 1.050 |
Why?
|
| Caregivers | 7 | 2023 | 180 | 1.040 |
Why?
|
| Scleroderma, Systemic | 8 | 2023 | 59 | 1.010 |
Why?
|
| Hospitals, Pediatric | 10 | 2021 | 128 | 0.980 |
Why?
|
| Health Services Accessibility | 5 | 2021 | 490 | 0.970 |
Why?
|
| Home Nursing | 2 | 2022 | 18 | 0.890 |
Why?
|
| Lung Diseases, Interstitial | 8 | 2023 | 292 | 0.870 |
Why?
|
| United States | 30 | 2023 | 7645 | 0.810 |
Why?
|
| Pediatrics | 4 | 2019 | 386 | 0.760 |
Why?
|
| Humans | 81 | 2025 | 93615 | 0.740 |
Why?
|
| Infant | 21 | 2023 | 3222 | 0.740 |
Why?
|
| Health Expenditures | 4 | 2021 | 102 | 0.720 |
Why?
|
| Child, Preschool | 22 | 2023 | 3832 | 0.710 |
Why?
|
| Primary Health Care | 4 | 2017 | 379 | 0.690 |
Why?
|
| Child Health | 2 | 2018 | 13 | 0.680 |
Why?
|
| Insurance | 1 | 2021 | 12 | 0.660 |
Why?
|
| Adolescent | 26 | 2022 | 9610 | 0.640 |
Why?
|
| Lung Diseases, Fungal | 1 | 2020 | 18 | 0.630 |
Why?
|
| Mucormycosis | 1 | 2020 | 16 | 0.630 |
Why?
|
| Health Equity | 1 | 2022 | 102 | 0.620 |
Why?
|
| Telemedicine | 2 | 2022 | 225 | 0.600 |
Why?
|
| Health Services | 2 | 2016 | 56 | 0.590 |
Why?
|
| Health Policy | 2 | 2019 | 207 | 0.590 |
Why?
|
| Rickets, Hypophosphatemic | 1 | 2019 | 1 | 0.590 |
Why?
|
| Infant Formula | 1 | 2019 | 18 | 0.580 |
Why?
|
| Carbohydrates | 1 | 2019 | 41 | 0.570 |
Why?
|
| Dietary Fats | 1 | 2019 | 135 | 0.550 |
Why?
|
| Phosphates | 1 | 2019 | 163 | 0.540 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.540 |
Why?
|
| Amino Acids | 1 | 2019 | 246 | 0.540 |
Why?
|
| Case Management | 1 | 2017 | 29 | 0.530 |
Why?
|
| Managed Care Programs | 1 | 2017 | 36 | 0.520 |
Why?
|
| Congresses as Topic | 1 | 2018 | 124 | 0.510 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 660 | 0.510 |
Why?
|
| Lung | 6 | 2025 | 1365 | 0.510 |
Why?
|
| Patient Readmission | 7 | 2019 | 412 | 0.510 |
Why?
|
| Hospitalization | 7 | 2021 | 938 | 0.500 |
Why?
|
| Nursing Homes | 1 | 2017 | 110 | 0.480 |
Why?
|
| Health Status Indicators | 1 | 2016 | 101 | 0.470 |
Why?
|
| Residence Characteristics | 1 | 2017 | 213 | 0.470 |
Why?
|
| Retrospective Studies | 23 | 2023 | 10186 | 0.450 |
Why?
|
| Transition to Adult Care | 1 | 2015 | 22 | 0.430 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 1866 | 0.420 |
Why?
|
| Infant, Newborn | 13 | 2021 | 2482 | 0.400 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 423 | 0.370 |
Why?
|
| Male | 33 | 2021 | 44578 | 0.360 |
Why?
|
| Continuity of Patient Care | 3 | 2019 | 176 | 0.350 |
Why?
|
| Pneumococcal Infections | 2 | 2023 | 46 | 0.340 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 110 | 0.340 |
Why?
|
| Comprehensive Health Care | 1 | 2011 | 14 | 0.340 |
Why?
|
| Female | 33 | 2022 | 48779 | 0.330 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2020 | 461 | 0.330 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 224 | 0.320 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 582 | 0.320 |
Why?
|
| Health Care Surveys | 6 | 2021 | 286 | 0.320 |
Why?
|
| Needs Assessment | 4 | 2018 | 172 | 0.310 |
Why?
|
| Forecasting | 2 | 2022 | 294 | 0.310 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 166 | 0.300 |
Why?
|
| Radiation Dosage | 3 | 2022 | 229 | 0.300 |
Why?
|
| Health Care Costs | 4 | 2021 | 252 | 0.290 |
Why?
|
| Neoplasm Staging | 2 | 2024 | 2018 | 0.290 |
Why?
|
| Patient Discharge | 5 | 2020 | 356 | 0.290 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 164 | 0.290 |
Why?
|
| Radiologists | 2 | 2025 | 57 | 0.270 |
Why?
|
| Illinois | 3 | 2014 | 520 | 0.250 |
Why?
|
| Health Resources | 3 | 2019 | 81 | 0.250 |
Why?
|
| Subacute Care | 2 | 2017 | 19 | 0.250 |
Why?
|
| Physicians | 2 | 2021 | 683 | 0.230 |
Why?
|
| Australia | 3 | 2022 | 123 | 0.230 |
Why?
|
| Diagnosis, Differential | 4 | 2025 | 1546 | 0.230 |
Why?
|
| Fixation, Ocular | 1 | 2025 | 50 | 0.220 |
Why?
|
| Mediastinal Diseases | 1 | 2025 | 22 | 0.220 |
Why?
|
| Mediastinal Neoplasms | 1 | 2025 | 43 | 0.220 |
Why?
|
| Thoracic Neoplasms | 1 | 2025 | 65 | 0.210 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2025 | 104 | 0.200 |
Why?
|
| Streptococcus pneumoniae | 2 | 2023 | 51 | 0.200 |
Why?
|
| Pericardium | 1 | 2024 | 72 | 0.200 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2023 | 39 | 0.200 |
Why?
|
| Colorado | 1 | 2023 | 39 | 0.190 |
Why?
|
| Refugees | 1 | 2022 | 7 | 0.190 |
Why?
|
| Radiology | 1 | 2025 | 201 | 0.180 |
Why?
|
| Social Work | 1 | 2022 | 21 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 51 | 0.180 |
Why?
|
| Technology | 1 | 2022 | 33 | 0.180 |
Why?
|
| Education, Medical, Continuing | 1 | 2023 | 102 | 0.180 |
Why?
|
| Vital Capacity | 2 | 2021 | 73 | 0.180 |
Why?
|
| Consensus | 2 | 2021 | 368 | 0.180 |
Why?
|
| Insurance Coverage | 2 | 2021 | 144 | 0.180 |
Why?
|
| Cooperative Behavior | 1 | 2023 | 192 | 0.180 |
Why?
|
| Developed Countries | 1 | 2021 | 25 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2021 | 3061 | 0.170 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 2806 | 0.170 |
Why?
|
| Pleural Neoplasms | 1 | 2023 | 201 | 0.170 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2021 | 58 | 0.170 |
Why?
|
| Multimorbidity | 1 | 2021 | 6 | 0.170 |
Why?
|
| Child, Hospitalized | 2 | 2019 | 41 | 0.160 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 496 | 0.160 |
Why?
|
| Health Services Research | 2 | 2011 | 143 | 0.160 |
Why?
|
| Length of Stay | 3 | 2019 | 828 | 0.160 |
Why?
|
| Cognition | 1 | 2025 | 627 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2019 | 2444 | 0.160 |
Why?
|
| Social Determinants of Health | 2 | 2018 | 108 | 0.150 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2019 | 2 | 0.150 |
Why?
|
| Respite Care | 1 | 2019 | 9 | 0.150 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 8 | 0.150 |
Why?
|
| Nursing, Private Duty | 1 | 2019 | 1 | 0.150 |
Why?
|
| Pandemics | 2 | 2024 | 875 | 0.150 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 32 | 0.150 |
Why?
|
| Young Adult | 6 | 2019 | 6938 | 0.150 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 137 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 129 | 0.150 |
Why?
|
| Multidetector Computed Tomography | 2 | 2024 | 57 | 0.150 |
Why?
|
| Workflow | 1 | 2019 | 78 | 0.140 |
Why?
|
| Sepsis | 1 | 2023 | 388 | 0.140 |
Why?
|
| Telomere Shortening | 1 | 2019 | 25 | 0.140 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 29 | 0.140 |
Why?
|
| Ataxia | 1 | 2019 | 46 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2019 | 64 | 0.140 |
Why?
|
| Adiponectin | 1 | 2018 | 21 | 0.140 |
Why?
|
| Cross Infection | 1 | 2020 | 155 | 0.140 |
Why?
|
| Drug Costs | 1 | 2019 | 66 | 0.140 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2019 | 139 | 0.140 |
Why?
|
| Noninvasive Ventilation | 1 | 2019 | 41 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 3 | 2019 | 154 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2022 | 374 | 0.140 |
Why?
|
| Hospital Costs | 2 | 2016 | 116 | 0.140 |
Why?
|
| Telomere | 1 | 2019 | 120 | 0.140 |
Why?
|
| Critical Care | 1 | 2021 | 444 | 0.130 |
Why?
|
| Health Maintenance Organizations | 1 | 2017 | 19 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 150 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3835 | 0.130 |
Why?
|
| Prevalence | 3 | 2017 | 1322 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2018 | 217 | 0.130 |
Why?
|
| Contrast Media | 1 | 2021 | 988 | 0.130 |
Why?
|
| Children's Health Insurance Program | 1 | 2016 | 2 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 435 | 0.120 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 27 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 110 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2017 | 108 | 0.120 |
Why?
|
| Respiratory Tract Diseases | 1 | 2016 | 45 | 0.120 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 395 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1723 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 202 | 0.120 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 25 | 0.120 |
Why?
|
| Catheter Ablation | 1 | 2019 | 348 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2013 | 822 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 293 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 774 | 0.110 |
Why?
|
| Esophagus | 1 | 2016 | 113 | 0.110 |
Why?
|
| Pregnancy | 1 | 2022 | 3148 | 0.110 |
Why?
|
| Tonsillectomy | 1 | 2014 | 31 | 0.110 |
Why?
|
| Adult | 8 | 2019 | 27955 | 0.110 |
Why?
|
| Cost Savings | 1 | 2014 | 68 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 64 | 0.100 |
Why?
|
| Emergencies | 1 | 2014 | 122 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 1923 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2014 | 214 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3479 | 0.100 |
Why?
|
| Medicare | 2 | 2016 | 455 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 1133 | 0.090 |
Why?
|
| State Health Plans | 1 | 2011 | 13 | 0.080 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 449 | 0.080 |
Why?
|
| Child Welfare | 1 | 2011 | 44 | 0.080 |
Why?
|
| Community Health Services | 1 | 2011 | 81 | 0.080 |
Why?
|
| Algorithms | 2 | 2020 | 1954 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 504 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2010 | 37 | 0.080 |
Why?
|
| Family | 2 | 2022 | 324 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2011 | 315 | 0.080 |
Why?
|
| Risk Factors | 1 | 2020 | 5912 | 0.070 |
Why?
|
| Logistic Models | 1 | 2013 | 1246 | 0.070 |
Why?
|
| Dilatation | 2 | 2021 | 47 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 3158 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 629 | 0.070 |
Why?
|
| Hospitals | 1 | 2011 | 330 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 758 | 0.070 |
Why?
|
| Hospitalists | 1 | 2010 | 136 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2718 | 0.070 |
Why?
|
| Inpatients | 1 | 2011 | 345 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2019 | 9108 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 3913 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 1907 | 0.060 |
Why?
|
| Mediastinum | 1 | 2025 | 43 | 0.050 |
Why?
|
| Middle Aged | 6 | 2020 | 27621 | 0.050 |
Why?
|
| Thorax | 1 | 2025 | 78 | 0.050 |
Why?
|
| Pulmonologists | 1 | 2024 | 7 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1715 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2025 | 149 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 990 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1165 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2025 | 203 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2564 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2023 | 33 | 0.050 |
Why?
|
| Artifacts | 1 | 2025 | 243 | 0.050 |
Why?
|
| Educational Status | 1 | 2024 | 197 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 350 | 0.040 |
Why?
|
| Seasons | 1 | 2023 | 240 | 0.040 |
Why?
|
| Insurance Carriers | 1 | 2021 | 5 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 230 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2023 | 277 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 24 | 0.040 |
Why?
|
| Nurse Practitioners | 1 | 2021 | 33 | 0.040 |
Why?
|
| Pelvis | 1 | 2021 | 100 | 0.040 |
Why?
|
| Mental Health | 1 | 2022 | 189 | 0.040 |
Why?
|
| Income | 1 | 2021 | 87 | 0.040 |
Why?
|
| Abdomen | 1 | 2021 | 120 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 136 | 0.040 |
Why?
|
| Learning | 1 | 2024 | 293 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 81 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2020 | 46 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 456 | 0.040 |
Why?
|
| Serogroup | 1 | 2020 | 11 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 23 | 0.040 |
Why?
|
| Skin | 1 | 2023 | 576 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 50 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 146 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 82 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 341 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2019 | 21 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 35 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 221 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Incidence | 1 | 2023 | 1702 | 0.040 |
Why?
|
| United Kingdom | 1 | 2019 | 190 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 302 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 91 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 364 | 0.030 |
Why?
|
| Patient Admission | 1 | 2018 | 119 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1007 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 269 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 657 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2019 | 454 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 43 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 2543 | 0.030 |
Why?
|
| Internet | 1 | 2018 | 346 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 51 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 298 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 729 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1104 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2018 | 383 | 0.030 |
Why?
|
| Poverty | 1 | 2017 | 193 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 4565 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 580 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 419 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 836 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1933 | 0.030 |
Why?
|
| Radiation Protection | 1 | 2013 | 27 | 0.020 |
Why?
|
| Radiometry | 1 | 2013 | 60 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 996 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2013 | 31 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1912 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 414 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 1006 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2011 | 7 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2011 | 159 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1950 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 68 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2013 | 484 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 20469 | 0.020 |
Why?
|
| Social Support | 1 | 2011 | 233 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 585 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 5406 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7073 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 594 | 0.010 |
Why?
|